Actively Recruiting
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
Led by University of Zurich · Updated on 2024-12-20
90
Participants Needed
1
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
LIMITFOOD2 is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of obese adults. A total of 90 participants will be randomized into three equally sized groups: a modified alternate day fasting, a time-restricted eating and a control group, receiving general weight-loss counseling.
CONDITIONS
Official Title
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 50 years, inclusive
- Obese with BMI between 30 and 40 kg/m2 (obesity grade I or II)
- Non-smoker
- Good knowledge of German or English
- Stable weight change (less than +/- 3% bodyweight) for 3 months before the study
- HbA1c less than 6.5% without glucose-lowering medication
- LDL cholesterol less than 4.6 mmol/l without lipid-lowering medication
You will not qualify if you...
- Regular fasting periods longer than 12 hours per day or eating fewer than three main meals daily
- Current use of dietary supplements or unwillingness to stop them
- Antibiotic use in the 3 months before the study
- Food intolerances, severe allergies, or dietary restrictions such as veganism
- Acute or chronic infections, cancer, kidney or liver disease (more than two-fold increased transaminases), lung, neurological, psychiatric diseases, or severe atherosclerosis
- Diabetes
- Known alcohol, substance, or drug abuse
- Use of certain medications including hormonal supplements, antidepressants within 6 months, acetylsalicylic acid, or drugs regulating blood sugar, blood pressure, or lipids
- More than four hours of exercise per week
- Pregnancy, breastfeeding, or planning pregnancy during the trial
- Irregular menstrual cycle according to FIGO criteria
- Likely inability to comply with study protocol
- Not providing informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Endocrinology, Diabetology and Clinical Nutrition
Zurich, Canton of Zurich, Switzerland, 8091
Actively Recruiting
Research Team
L
Leonie Mönch, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here